story of the week
Pyrotinib or Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study
J. Clin. Oncol 2019 Aug 20;[EPub Ahead of Print], F Ma, Q Ouyang, W Li, Z Jiang, Z Tong, Y Liu, H Li, S Yu, J Feng, S Wang, X Hu, J Zou, X Zhu, B XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.